title: Maternal phenylketonuria: a metabolic teratogen.
abstract: The maternal phenylketonuria (PKU) syndrome refers to the teratogenic effects of PKU during pregnancy. These effects include mental retardation, microcephaly, congenital heart disease, and intrauterine growth retardation. In untreated pregnancies wherein the mother has classic PKU with a blood phenylalanine level > or = 1,200 microM (20 mg/dl), the frequencies of these abnormalities in offspring are exceedingly high, approaching 75-90% for microcephaly and mental retardation and 15% for congenital heart disease. There is a dose response relationship with progressively lower frequencies of these abnormalities at lower phenylalanine levels, both in the pregnancies of women with variants of PKU and in treated classic PKU pregnancies. The pathogenesis of this syndrome is unknown; it may be related to inhibition by phenylalanine of large neutral amino acid transport across the placenta or to direct toxicity of phenylalanine and/or a phenylalanine metabolite in certain fetal organs. A mouse model for PKU now exists, and studies of maternal PKU in this model are in progress. The treatment of maternal PKU consists of biochemical control through a phenylalanine restricted diet during pregnancy. The best results are obtained with diet initiation before conception or no later than the earliest weeks of pregnancy. Women with PKU and their families require much psychosocial support to meet the strict requirements of a maternal PKU pregnancy, including compliance with a difficult diet. With such compliance, however, it seems that bearing normal or near normal offspring is possible.
authors: Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
authors: H L
authors: HL
authors: Levy
authors: M
authors: M
authors: Ghavami
mesh_terms: D000015:Abnormalities, Multiple / Q000209:etiology*; D000437:Alcoholism / Q000175:diagnosis; D000818:Animals; D003937:Diagnosis, Differential; D004195:Disease Models, Animal; D005145:Face / Q000002:abnormalities; D005260:Female; D063647:Fetal Alcohol Spectrum Disorders / Q000175:diagnosis; D005317:Fetal Growth Retardation / Q000209:etiology; D005817:Genetic Counseling; D006330:Heart Defects, Congenital / Q000209:etiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008607:Intellectual Disability / Q000209:etiology; D008297:Male; D051379:Mice; D008831:Microcephaly / Q000209:etiology; D010661:Phenylketonurias / Q000175:diagnosis / Q000517:prevention & control*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000517:prevention & control*